Publications by authors named "Karadi Eva"

Claim this Profile
F
Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients.
Egyed Miklos, Tóth Peter Oliver, Kellner Adam, Karadi Eva, Kollar Balazs

Eur J Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia register.
Eva Karadi, Peter Dombi, Viktoria Gyorine Korom, Eszter Kovacs, Jozsef Herczeg

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Event-Free Survival Prediction in DLBCL Patients Based on Radiomics and Clinical Parameters.
Zsombor Ritter, László Papp, Katalin Zámbó, Zoltán Tóth, Dániel Dezső

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anagrelide influences thrombotic risk, and prolongs progression-free and overall survival in essential thrombocythaemia vs hydroxyurea plus aspirin.
Adam Kellner, Peter Dombi, Arpad Illes, Judit Demeter, Lajos Homor, Eva Karadi

Eur J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the Polycythemia vera patients].
Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon

Orv Hetil· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin.
Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsofia Simon, Eva Karadi

Eur J Haematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the essential thrombocythaemic patients].
Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon

Orv Hetil· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Low mean cell hemoglobin is a reliable marker for iron deficiency screening].
Sára Vászana Kellner, Ádám Kellner, Attila Haragh, Péter Dombi, Éva Karádi

Orv Hetil· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Imatinib therapy in chronic myeloid leukemia].
Miklós Egyed, Balázs Kollár, Péter Rajnics, Eva Karádi, András Matolcsi

Orv Hetil· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Neutropenia and sepsis in hematologic patients].
Miklós Egyed, Balázs Kollár, Eva Karádi, Péter Rajnics, Lívia Kocsondi

Orv Hetil· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis